FDSVX
Price
$62.66
Change
-$0.88 (-1.38%)
Updated
Jun 13 closing price
Net Assets
5.96B
RGEBX
Price
$74.89
Change
-$0.91 (-1.20%)
Updated
Jun 13 closing price
Net Assets
306.22B
Interact to see
Advertisement

FDSVX vs RGEBX

Header iconFDSVX vs RGEBX Comparison
Open Charts FDSVX vs RGEBXBanner chart's image
Fidelity Growth Discovery
Price$62.66
Change-$0.88 (-1.38%)
VolumeN/A
Net Assets5.96B
American Funds Growth Fund of Amer R2E
Price$74.89
Change-$0.91 (-1.20%)
VolumeN/A
Net Assets306.22B
FDSVX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FDSVX vs. RGEBX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDSVX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 306B vs. FDSVX (5.96B). FDSVX (0.00) and RGEBX (0.00) have matching dividends . FDSVX was incepted earlier than RGEBX: FDSVX (27 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than FDSVX (0.66). FDSVX is a more actively managed with annual turnover of: 41.00 vs. RGEBX (25.00). FDSVX has a lower initial minimum investment than RGEBX: FDSVX (0) vs RGEBX (250). RGEBX annual gain was more profitable for investors over the last year : 7.68 vs. FDSVX (-3.72). FDSVX (45.97) and RGEBX (45.42) have equivalent 5 years return.
FDSVXRGEBXFDSVX / RGEBX
Total Expense Ratio0.661.0961%
Annual Report Gross Expense Ratio0.661.0961%
Fund Existence27 years11 years-
Gain YTD1.6554.82934%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets5.96B306B2%
Annual Yield % from dividends0.000.00-
Returns for 1 year-3.727.68-48%
Returns for 3 years50.8251.01100%
Returns for 5 years45.9745.42101%
Returns for 10 years150.5765.87229%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APGE44.482.62
+6.26%
Apogee Therapeutics
VVOS2.140.01
+0.47%
Vivos Therapeutics
SJM95.72-1.65
-1.69%
JM Smucker Company (The)
ELVA3.38-0.17
-4.79%
Electrovaya
NNDM1.44-0.12
-7.69%
Nano Dimension Ltd